FinancingNK cell therapy company NK:IO raises seed moneyLatest NewsBritish NK cell therapy specialist NK:IO Ltd has added a £1.2m seed investment led by Cancer Research Horizons, bringing total seed funding to £5.1m. Read more 25 July 2023 https://european-biotechnology.com/wp-content/uploads/2024/04/Research_team-NK-IO_Ltd.jpg 468 572 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2023-07-25 09:33:002024-07-09 15:02:06NK cell therapy company NK:IO raises seed money